KDI Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$11.3M Sell
19,794
-153
-0.8% -$84K 3.91% 12
2021
Q2
$10.1M Buy
19,947
+1,434
+8% +$677K 3.32% 18
2021
Q1
$8.45M Sell
18,513
-293
-2% -$140K 3.28% 18
2020
Q4
$8.76M Sell
18,806
-339
-2% -$159K 3.96% 14
2020
Q3
$8.45M Sell
19,145
-405
-2% -$167K 4.22% 12
2020
Q2
$7.08M Sell
19,550
-14,126
-42% -$4.73M 3.69% 17
2020
Q1
$9.55M Buy
+33,676
New +$10.6M 4.32% 12

Other funds holding TMO

KDI Capital Partners's TMO Position: Q3 2021 in Review

KDI Capital Partners reduced its Thermo Fisher Scientific (TMO) stake by 0.77% in Q3 2021, selling an estimated $84K and leaving 19,794 shares worth $11.3M. The position accounts for 3.91% of the portfolio, ranked #12.

KDI Capital Partners first reported a position in TMO in Q1 2020 and has held it in 7 quarters since. 2,128 funds tracked by Wall St. Rank hold TMO as of Q3 2021.

  • KDI Capital Partners held 19,794 shares of Thermo Fisher Scientific worth $11.3M as of Q3 2021.
  • KDI Capital Partners sold 153 Thermo Fisher Scientific shares in Q3 2021, an estimated $84K.
  • Thermo Fisher Scientific made up 3.91% of KDI Capital Partners's portfolio in Q3 2021, its #12 holding.
  • KDI Capital Partners first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 7 quarters since.
  • 2,128 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2021.

Based on KDI Capital Partners's 13F filing for Q3 2021, filed 12 Nov 2021.